High-risk NB and MYC-amplified MBG3 models demonstrate good RA sensitivity with absolute half-maximal inhibitory concentrations (IC50 values) well below the peak serum concentration (Cmax) for the standard dosing regimen in paediatric oncology [18] (Fig. 1a–c, Supplementary Table S4). This evidence concerns the gene MYC and neuroblastoma.